Some investors downplay the link between politics and investing, and sometimes Capitol Hill events have little impact. But if it were all irrelevant, why would so many members of Congress trade stocks based on the information they receive? Reality shows that sometimes, our nation’s leaders leave promising investment opportunities hiding in plain sight. For example, on March 14, Congress passed a continuing resolution (CR) to fund the government through the summer. Not only does this prevent a government shu ...

Axon Enterprise (AXON) closed at $554.39 in the latest trading session, marking a -0.34% move from the prior day. The stock's performance was behind the S&P 500's daily gain of 0.64%. Elsewhere, the Dow gained 0.85%, while the tech-heavy Nasdaq added 0.31%.The maker of stun guns and body cameras's stock has dropped by 18.61% in the past month, falling short of the Aerospace sector's gain of 1.09% and the S&P 500's loss of 7.69%.The upcoming earnings release of Axon Enterprise will be of great interest to in ...

Core Viewpoint - The article discusses the investment position of Parkev Tatevosian, CFA, and mentions the involvement of The Motley Fool with Axon Enterprise, highlighting the potential for financial compensation through affiliate links [1] Group 1 - Parkev Tatevosian has no position in any of the stocks mentioned [1] - The Motley Fool has positions in and recommends Axon Enterprise [1] - Parkev Tatevosian is an affiliate of The Motley Fool and may be compensated for promoting its services [1]

Tariffs and the threat trade wars pose on the global economy are weighing on the markets right now. How long this will last and how devastating the impact will be on businesses has many investors hitting the panic button. There could, however, be some good, relatively safe stocks to buy amid all this turmoil. Three investments you may want to consider loading up on right now are Alibaba Group Holdings (BABA 0.88%), Visa (V -1.29%), and Axon Enterprise (AXON -4.18%). Here's why I think these stocks can outpe ...

SCOTTSDALE, Ariz., March 7, 2025 /PRNewswire/ -- Axon Enterprise, Inc. (Nasdaq: AXON) ("Axon") announced today that it has entered into separate, privately negotiated exchange agreements with certain holders of its 0.50% convertible senior notes due 2027 (the "Notes"). Pursuant to these exchange agreements, Axon has agreed, subject to customary closing conditions, to exchange approximately $407.5 million aggregate principal amount of the Notes for exchange consideration consisting of cash and shares of its ...

SCOTTSDALE, Ariz., March 5, 2025 /PRNewswire/ -- Axon (Nasdaq: AXON) ("Axon") announced today that it has priced $1,000.0 million aggregate principal amount of its Senior Notes due 2030 (the "2030 Notes") at an issue price of 100% and $750.0 million aggregate principal amount of its Senior Notes due 2033 at an issue price of 100% (the "2033 Notes" and, together with the 2030 Notes, the "Notes") in a private offering that is exempt from the registration requirements of the Securities Act of 1933, as amended ...

SCOTTSDALE, Ariz., March 5, 2025 /PRNewswire/ -- Axon Enterprise, Inc. (Nasdaq: AXON) ("Axon") announced today that it intends to offer, subject to market and other conditions, $1,500.0 million aggregate principal amount of senior notes, comprising senior notes due 2030 (the "2030 Notes") and senior notes due 2033 (the "2033 Notes" and, together with the 2030 Notes, the "Notes") in a private offering that is exempt from the registration requirements of the Securities Act of 1933, as amended (the "Securities ...

Core Insights - The article discusses the positions held by Travis Hoium in Axon Enterprise and mentions that The Motley Fool has positions in and recommends Axon Enterprise [1] Company Insights - Axon Enterprise is highlighted as a company of interest due to its association with Travis Hoium and The Motley Fool, indicating potential investment relevance [1]

Financial Performance - Net sales increased to $2,082,526 thousand in 2024, up 33.3% from $1,560,699 thousand in 2023[369]. - Net income for 2024 reached $377,034 thousand, representing a 114.1% increase compared to $175,783 thousand in 2023[369]. - Gross margin improved to $1,241,380 thousand in 2024, up from $955,453 thousand in 2023, indicating a significant increase in profitability[369]. - Research and development expenses rose to $441,593 thousand in 2024, a 45.5% increase from $303,719 thousand in 2023, reflecting the company's commitment to innovation[369]. - Total assets grew to $4,474,588 thousand in 2024, compared to $3,409,174 thousand in 2023, marking a 31.2% increase[366]. - Total liabilities increased to $2,146,923 thousand in 2024, up from $1,793,409 thousand in 2023, indicating a rise of 19.7%[366]. - Retained earnings surged to $812,014 thousand in 2024, compared to $434,980 thousand in 2023, showing a growth of 86.5%[366]. - The company reported a basic net income per share of $4.98 in 2024, up from $2.37 in 2023, reflecting a 110.5% increase[369]. - Cash and cash equivalents decreased to $454,844 thousand in 2024 from $598,545 thousand in 2023, a decline of 24.1%[366]. - The company reported a net cash used in investing activities of $(490,573) in 2024, compared to a net cash provided of $12,476 in 2023[374]. - Stock-based compensation increased significantly to $382,604 in 2024 from $131,358 in 2023, marking a 191% increase[374]. - The company reported a loss on strategic investments and marketable securities of $(283,217) in 2024, compared to a gain of $41,785 in 2023[374]. - Net cash provided by operating activities increased to $408,312 in 2024 from $189,263 in 2023, a growth of 116%[374]. Revenue Recognition and Contracts - The company recognizes revenue from two primary sources: product sales and subscriptions to the Axon Evidence SaaS offering[410]. - The company applies the five-step revenue recognition model outlined in ASC 606 for contracts with multiple performance obligations[411]. - Contract assets increased by $116.2 million, or 31.3%, to $487.8 million in 2024, driven by increased sales under subscription plans[461]. - Contract liabilities (deferred revenue) rose by $232.3 million, or 31.3%, to $973.6 million in 2024, attributed to acquisitions and increased subscription invoicing[461]. - Remaining performance obligations as of December 31, 2024, were approximately $7.9 billion, with an expectation to recognize 20%-25% over the next 12 months[464]. Investments and Financial Instruments - The company invests in a portfolio of marketable and non-marketable securities, with potential unrealized losses affecting earnings performance[221]. - A hypothetical 100 basis point increase in interest rates would result in a $0.7 million decline in the fair market value of the investment portfolio[357]. - The company has access to a $200.0 million line of credit, with available borrowings reduced by outstanding letters of credit totaling $7.8 million[358]. - The company has not engaged in any currency hedging activities, exposing it to foreign exchange rate risks[361]. - The company faces counterparty risk with respect to the 2027 Note Hedge transactions, which could adversely affect its financial results[260]. - The company issued $690.0 million aggregate principal amount of 2027 Notes, with net proceeds of approximately $673.8 million after deducting costs[500]. - The effective interest rate for the 2027 Notes is 0.99%, with total interest expense of $6.627 million for the year ended December 31, 2024[505]. - The estimated fair value of the 2027 Notes increased to $1,798.5 million as of December 31, 2024, compared to $873.3 million as of December 31, 2023[505]. Legal and Regulatory Risks - Legal claims related to product liability and intellectual property could result in significant costs and adversely affect business prospects[222][229]. - The company faces risks from class action lawsuits that could lead to substantial monetary judgments and reputational harm[224]. - The ability to enforce patent rights internationally may be limited, impacting the company's competitive position in foreign markets[237]. - Open-source software use may expose the company to risks that could harm its intellectual property and business operations[238]. - New and existing laws and regulations could materially and adversely affect the company's business operations and compliance requirements[240]. - The evolving nature of laws and regulations may lead to uncertainties that could impact the company's policies and practices[241]. - The company is subject to evolving corporate governance and public disclosure regulations, which may increase general and administrative expenses[243]. Assets and Liabilities - Total cash and cash equivalents at the end of 2024 were $466,763, down from $600,670 at the end of 2023, a decrease of 22%[374]. - The company holds cash and cash equivalents totaling $454,844 as of December 31, 2024, down from $598,545 in 2023[392]. - Total inventory decreased to $265.3 million as of December 31, 2024, from $269.9 million in 2023, with provisions to reduce inventories amounting to approximately $17.8 million[481]. - The total allowance for expected credit losses on customer receivables was $5.6 million as of December 31, 2024, up from $4.0 million in 2023[480]. - The company recorded provisions to reduce inventories to their lower of cost or net realizable value of approximately $17.8 million in 2024, compared to $5.4 million in 2023[481]. - The company recognized a warranty expense of $5.591 million in 2024, a decrease from $8.062 million in 2023, indicating improved product reliability or cost management[428]. Strategic Growth and Innovation - The company’s strategic investments increased to $332,550 thousand in 2024, compared to $231,730 thousand in 2023, representing a growth of 43.5%[366]. - The company recognized an unrealized gain of $75.6 million for a strategic investment during the year ended December 31, 2024[491]. - The company exercised call options and acquired the remaining outstanding stock of two strategic investments, resulting in net non-taxable gains of $42.3 million and $51.6 million for Fusus and Dedrone, respectively[490]. - The company is currently evaluating the impact of new accounting standards on its consolidated financial statements, including ASU 2023-09 and ASU 2024-03[454][457]. Shareholder and Governance Matters - The company’s amended and restated bylaws include exclusive forum provisions that may limit shareholders' ability to bring claims in favorable judicial forums[248]. - The conditional conversion feature of the Notes may adversely affect the company's liquidity if triggered[251]. - The total potentially dilutive securities increased to 8.790 million in 2024 from 7.048 million in 2023, reflecting changes in stock-based awards and convertible notes[452]. - The weighted average shares outstanding increased to 75.748 million in 2024 from 74.195 million in 2023, contributing to the earnings per share growth[452].

Axon Enterprise, Inc. (AXON) reported better-than-expected fourth-quarter 2024 results on Tuesday. Earnings per share surpassed the Zacks Consensus Estimate by 36% and surged 84.1% year over year.Total revenues of $575.1 million surpassed the consensus estimate of $566.1 million and increased 34% year over year. The fourth-quarter results benefited from solid momentum in its TASER and Software & Sensors segments.Find the latest EPS estimates and surprises on Zacks Earnings Calendar.AXON has been reporting s ...